Document is current
Any future updates will be listed below
-
Authors
Ikhile, Deborah https://orcid.org/0000-0002-4343-1674
Highton, Patrick https://orcid.org/0000-0002-0410-5788
Gillies, Clare
Abdala, Ruksar
Ardavani, Ashkon https://orcid.org/0000-0002-9442-3295
Arora, Monika https://orcid.org/0000-0001-9987-3933
Banstola, Amrit https://orcid.org/0000-0003-3185-9638
Brahmbhatt, Aakrushi
Cassambai, Shabana https://orcid.org/0000-0001-6201-9063
Funnell, Mark P. https://orcid.org/0000-0001-7473-5999
Goenka, Shifalika https://orcid.org/0000-0001-6993-2883
Jeffers, Shavez https://orcid.org/0000-0001-7542-1772
Kondal, Dimple
Mohan, Sailesh
Mulakalapalli, Prakash https://orcid.org/0009-0000-9303-4741
Oli, Natalia
Peace, Arron https://orcid.org/0009-0005-3859-2907
Singh, Kuldeep https://orcid.org/0000-0002-9375-3233
Vaidya, Abhinav
Venkateshmurthy, Nikhil Srinivasapura https://orcid.org/0000-0003-4037-6371
Prabhakaran, Dorairaj https://orcid.org/0000-0002-3172-834X
Khunti, Kamlesh
- License Information
-
More Information
Article History
Received: 5 March 2025
Accepted: 16 December 2025
First Online: 26 January 2026
Competing interests
: K.K. has acted as a consultant, speaker or received grants for investigator-initiated studies for Astra Zeneca, Bayer, Novo Nordisk, Sanofi-Aventis, Servier, Lilly and Merck Sharp & Dohme, Boehringer Ingelheim, Oramed Pharmaceuticals, Pfizer, Roche, Daiichi-Sankyo, Applied Therapeutics, Embecta and Nestle Health Science. The remaining authors declare no competing interests.
